Alterity Therapeutics Limited (ATHE)

Alterity Therapeutics Statistics

Total Valuation

ATHE has a market cap or net worth of $71.70 million. The enterprise value is $45.00 million.

Market Cap	71.70M
Enterprise Value	45.00M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

ATHE has 9.21 billion shares outstanding. The number of shares has increased by 75.31% in one year.

Current Share Class	n/a
Shares Outstanding	9.21B
Shares Change (YoY)	+75.31%
Shares Change (QoQ)	+40.78%
Owned by Insiders (%)	5.50%
Owned by Institutions (%)	31.70%
Float	8.60B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20.11
Forward PS	n/a
PB Ratio	2.58
P/TBV Ratio	2.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	12.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.98, with a Debt / Equity ratio of 0.00.

Current Ratio	12.98
Quick Ratio	12.62
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -43.23% and return on invested capital (ROIC) is -32.43%.

Return on Equity (ROE)	-43.23%
Return on Assets (ROA)	-28.09%
Return on Invested Capital (ROIC)	-32.43%
Return on Capital Employed (ROCE)	-34.50%
Revenue Per Employee	$396,200
Profits Per Employee	-$884,914
Employee Count	9
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

In the past 12 months, ATHE has paid $44,617 in taxes.

Income Tax	44,617
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +205.36% in the last 52 weeks. The beta is 0.32, so ATHE's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	+205.36%
50-Day Moving Average	4.83
200-Day Moving Average	4.13
Relative Strength Index (RSI)	44.13
Average Volume (20 Days)	17,859

Short Selling Information

Short Interest	71,196
Short Previous Month	90,932
Short % of Shares Out	0.40%
Short % of Float	n/a
Short Ratio (days to cover)	6.02

Income Statement

In the last 12 months, ATHE had revenue of $3.57 million and -$7.96 million in losses. Loss per share was -$0.00.

Revenue	3.57M
Gross Profit	3.48M
Operating Income	-9.61M
Pretax Income	-7.92M
Net Income	-7.96M
EBITDA	-9.59M
EBIT	-9.61M
Loss Per Share	-$0.00

Balance Sheet

The company has $26.66 million in cash and $101,919 in debt, giving a net cash position of $26.55 million or $0.00 per share.

Cash & Cash Equivalents	26.66M
Total Debt	101,919
Net Cash	26.55M
Net Cash Per Share	$0.00
Equity (Book Value)	27.80M
Book Value Per Share	0.00
Working Capital	27.76M

Cash Flow

Operating Cash Flow	-7.51M
Capital Expenditures	n/a
Free Cash Flow	-7.53M
FCF Per Share	-$0.00

Margins

Gross margin is 97.66%, with operating and profit margins of -269.57% and -223.35%.

Gross Margin	97.66%
Operating Margin	-269.57%
Pretax Margin	-222.10%
Profit Margin	-223.35%
EBITDA Margin	-269.05%
EBIT Margin	-269.57%
FCF Margin	n/a

Dividends & Yields

ATHE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-75.31%
Shareholder Yield	-75.31%
Earnings Yield	-11.11%
FCF Yield	-10.51%

Analyst Forecast

The average price target for ATHE is $12.00, which is 180.70% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.00
Price Target Difference	180.70%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	81.80%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 9, 2023. It was a reverse split with a ratio of 1:10.

Last Split Date	Jan 9, 2023
Split Type	Reverse
Split Ratio	1:10

Scores

ATHE has an Altman Z-Score of 1.05 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.05
Piotroski F-Score	3